Spelling suggestions: "subject:"chondrocyte hypertrophy"" "subject:"chondrocytes hypertrophy""
1 |
Longitudinal growth of mammalian bones : a possible role for membrane transporters in mediating chondrocyte hypertrophyMohamad Yusof, Loqman January 2012 (has links)
Long bone lengthening occurs at the growth plate (GP) by well-regulated chondrocyte proliferation, hypertrophy and terminal matrix deposition. GP chondrocyte (GPC) hypertrophy has been implicated to be the main determinant of bone growth rate; however the mechanism is poorly understood. The work of this thesis examined some of the cellular process that drives the chondrocyte swelling or hypertrophy particularly in a mammalian post natal GPs using living in situ GPC and fixed GP tissues. Confocal scanning microscopy (CLSM) was used to determine living in situ GPC volume and dimension changes in proliferative zone (PZ) through to hypertrophic zone (HZ) chondrocytes of different GPs of various bones. While PZ cells showed similar volumes and dimensions, HZ cells varied in different GPs, even within the same long bone but at opposite ends. However, the hypertrophic cell volume measured at a single post natal age (day 7) was independent of the corresponding bone length. This could reflect a complex interplay between local and systemic factors in different GPs, which occurs throughout the active phase of bone growth. Maintaining GPC morphology was critical in studying GPC hypertrophy using fixed tissues. This work highlighted a problem caused by conventional fixative solutions, which caused up to 44% hypertrophic GPC shrinkage following GP fixation. This artifact appeared to be associated with the hyperosmotic nature of the fixatives used and could be abolished by adjusting the fixative osmolarity close to physiological level (280 mOsm), or could be significantly reduced by bisecting bone tissues prior to tissue fixation. This thesis proposed roles for plasma membrane transporter(s) in mediating GPC hypertrophy. This hypothesis was tested by examining roles of sodium-hydrogen exchanger (NHE) and anion exchanger (AE) in GPC hypertrophy using an ex vivo bone growth inhibition model. Inhibition of bone growth by inhibitors of NHE (EIPA) and AE (DIDS) respectively was shown to be dose-dependent. The histology of bones demonstrated that the late HZ width was significantly reduced in GPs treated with EIPA or DIDS. Although in situ GPC volumes in the PZ and HZ were not notably different in DIDS-treated GP, the cell volumes in both zones were significantly reduced by EIPA treatment. Fluorescence immunohistochemistry revealed distinctive cellular localisations of NHE1 and AE2 in the PZ and early HZ. These results suggest a possible role of AE in mediating GPC volume increase in PZ chondrocytes and those in the early stages of cell hypertrophy, whereas NHE could possibly maintain intracellular pH of GPC throughout all GP zones. This thesis has characterized various changes in volume and dimensions of living in situ GPC from PZ through to HZ of different GPs of postnatal rats. This work emphasized the importance of fixative osmolarity in order to accurately preserve the normal volume/morphology of cells within tissues. Most importantly, this thesis confirmed a potential role of the plasma membrane transporters, AE and NHE in GPC hypertrophy of growing bones.
|
2 |
The Biological Basis of Joint Ankylosis: Studies in the ank/ank MouseLas Heras, Facundo 08 March 2011 (has links)
The first objective of my work was to use the ank/ank (progressive ankylosis) mutant mice, which have a deficiency in inorganic pyrophosphate transport, to address the role of Ank in joint ankylosis. I observed the presence of hypertrophic chondrocytes in the uncalcified ank/ank mice articular cartilage. This novel phenotype is likely due to a dysregulation of chondrocyte maturation as these chondrocytes expressed hypertrophic chondrocyte markers (collagen type X and tissue non-specific alkaline phosphatase). I also showed by immunohistochemical staining that beta-catenin expression was upregulated and localized in the nuclei of articular ank/ank chondrocytes, suggesting activation of Wnt/beta-catenin signaling in these chondrocytes.
The second objective was to use ank/ank mice as an informative model for understanding ankylosis mechanisms in human ankylosing spondylitis (AS) patients, as WNT/beta-catenin signaling plays an important role in ankylosis in AS patients. We attempted rescue of joint ankylosis in ank/ank mice by gene transfer of noggin, an antagonist of BMP signaling. Paradoxically, noggin-treated ank/ank mice had accelerated ankylosis, as evidenced by joint pathology and IHC staining of beta-catenin showed more intense signals in the spinal chondrocytes of the treated mice. As noggin and sclerostin (an antagonist of beta-catenin signaling) form a mutually inhibitory complex, we hypothesize that the formation of this complex results in relieving suppression of both beta-catenin and BMP signaling, leading to more severe ankylosis in ank/ank mice.
By quantitative molecular imaging, I have demonstrated that ankylosis in these mutant mice developed simultaneously in distal and axial joint, instead of being a centripetal process.
In summary, I have made three original observations in the ank/ank mice: the hypertrophic chondrocyte phenotype; activation of beta-catenin signaling and the simultaneous development of ankylosis in distal and axial joints. These mutant mice serve as valuable model for pre-clinical studies which enable modeling and testing of novel anti-ankylosis treatments.
|
3 |
The Biological Basis of Joint Ankylosis: Studies in the ank/ank MouseLas Heras, Facundo 08 March 2011 (has links)
The first objective of my work was to use the ank/ank (progressive ankylosis) mutant mice, which have a deficiency in inorganic pyrophosphate transport, to address the role of Ank in joint ankylosis. I observed the presence of hypertrophic chondrocytes in the uncalcified ank/ank mice articular cartilage. This novel phenotype is likely due to a dysregulation of chondrocyte maturation as these chondrocytes expressed hypertrophic chondrocyte markers (collagen type X and tissue non-specific alkaline phosphatase). I also showed by immunohistochemical staining that beta-catenin expression was upregulated and localized in the nuclei of articular ank/ank chondrocytes, suggesting activation of Wnt/beta-catenin signaling in these chondrocytes.
The second objective was to use ank/ank mice as an informative model for understanding ankylosis mechanisms in human ankylosing spondylitis (AS) patients, as WNT/beta-catenin signaling plays an important role in ankylosis in AS patients. We attempted rescue of joint ankylosis in ank/ank mice by gene transfer of noggin, an antagonist of BMP signaling. Paradoxically, noggin-treated ank/ank mice had accelerated ankylosis, as evidenced by joint pathology and IHC staining of beta-catenin showed more intense signals in the spinal chondrocytes of the treated mice. As noggin and sclerostin (an antagonist of beta-catenin signaling) form a mutually inhibitory complex, we hypothesize that the formation of this complex results in relieving suppression of both beta-catenin and BMP signaling, leading to more severe ankylosis in ank/ank mice.
By quantitative molecular imaging, I have demonstrated that ankylosis in these mutant mice developed simultaneously in distal and axial joint, instead of being a centripetal process.
In summary, I have made three original observations in the ank/ank mice: the hypertrophic chondrocyte phenotype; activation of beta-catenin signaling and the simultaneous development of ankylosis in distal and axial joints. These mutant mice serve as valuable model for pre-clinical studies which enable modeling and testing of novel anti-ankylosis treatments.
|
4 |
Rôle de ShcA dans l'athérosclérose et dans la différenciation des chondrocytes / Role of ShcA in atherosclerosis and chondrocyte differentiationAbou Jaoude, Antoine 19 December 2018 (has links)
ShcA (Src Homology and Collagen A) est une protéine adaptatrice qui se lie à la partie cytoplasmique de LRP1 (Low Density Lipoprotein-related receptor 1), un récepteur transmembranaire qui protège contre l'athérosclérose. La calcification vasculaire est une complication majeure de cette maladie et ses mécanismes ressemblent au processus d’ostéochondrogenèse. Nous avons étudié le rôle de ShcA endothélial dans la formation des lésions d’athérosclérose ainsi que les rôles de ShcA et LRP1 dans la chondrogenèse. ShcA endothélial participe à la formation des lésions d’athérosclérose in-vivo. En inhibant la NOS endothéliale et activant l’expression de ICAM-1 via ZEB1, ShcA favorise l’adhésion des monocytes. La suppression de ShcA dans les chondrocytes a conduit au développement de souris présentant un phénotype de nanisme par une inhibition de la différenciation hypertrophique des chondrocytes. Ceci conduit également à une diminution du développement de l’arthrose liée au vieillissement. La suppression de LRP1 dans les chondrocytes conduit également à un phénotype de nanisme chez la souris, mais par des mécanismes différents. / ShcA (Src Homology and Collagen A) is an adaptor protein that binds to the cytoplasmic tail of the Low Density Lipoprotein-related receptor1 (LRP1), a trans-membrane receptor that protects against atherosclerosis. Vascular calcification is a major complication of this disease and its mechanisms highly resemble the process of osteochondrogenesis. We studied the role of endothelial ShcA in atherosclerotic lesion formation as well as the roles of ShcA and LRP1 in chondogenesis. Endothelial ShcA participates in the formation of atherosclerotic lesions in-vivo. By inhibiting endothelial NOS and activating the expression of ICAM-1 via ZEB1, ShcA enhances monocyte adhesion. The deletion of ShcA in chondrocytes led to the development of mice with a dwarfism phenotype by inhibiting chondrocyte hypertrophic differentiation. This also led to a decrease in the development of age-related osteoarthritis. The deletion of LRP1 in chondrocytes also led to a dwarfism phenotype in our mouse model, but trough different mechanisms.
|
Page generated in 0.0683 seconds